OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Recapitulating lipid accumulation and related metabolic dysregulation in human liver-derived organoids
Ling Wang, Meng Li, Bingting Yu, et al.
Journal of Molecular Medicine (2022) Vol. 100, Iss. 3, pp. 471-484
Open Access | Times Cited: 18
Ling Wang, Meng Li, Bingting Yu, et al.
Journal of Molecular Medicine (2022) Vol. 100, Iss. 3, pp. 471-484
Open Access | Times Cited: 18
Showing 18 citing articles:
Antioxidant Peptides from Miiuy Croaker Swim Bladders: Ameliorating Effect and Mechanism in NAFLD Cell Model through Regulation of Hypolipidemic and Antioxidant Capacity
Yumei Wang, Ming-Xue Ge, Suzhen Ran, et al.
Marine Drugs (2025) Vol. 23, Iss. 2, pp. 63-63
Open Access | Times Cited: 5
Yumei Wang, Ming-Xue Ge, Suzhen Ran, et al.
Marine Drugs (2025) Vol. 23, Iss. 2, pp. 63-63
Open Access | Times Cited: 5
Dissecting the multifaceted impact of statin use on fatty liver disease: a multidimensional study
Ibrahim Ayada, Laurens A. van Kleef, Huai Zhang, et al.
EBioMedicine (2022) Vol. 87, pp. 104392-104392
Open Access | Times Cited: 63
Ibrahim Ayada, Laurens A. van Kleef, Huai Zhang, et al.
EBioMedicine (2022) Vol. 87, pp. 104392-104392
Open Access | Times Cited: 63
Human liver cancer organoids: Biological applications, current challenges, and prospects in hepatoma therapy
Lichan Chen, Xiafei Wei, Dayong Gu, et al.
Cancer Letters (2023) Vol. 555, pp. 216048-216048
Closed Access | Times Cited: 33
Lichan Chen, Xiafei Wei, Dayong Gu, et al.
Cancer Letters (2023) Vol. 555, pp. 216048-216048
Closed Access | Times Cited: 33
Organoid-guided precision hepatology for metabolic liver disease
Sho Osonoi, Takanori Takebe
Journal of Hepatology (2024) Vol. 80, Iss. 5, pp. 805-821
Closed Access | Times Cited: 11
Sho Osonoi, Takanori Takebe
Journal of Hepatology (2024) Vol. 80, Iss. 5, pp. 805-821
Closed Access | Times Cited: 11
Applications of human organoids in the personalized treatment for digestive diseases
Qinying Wang, Fanying Guo, Yutao Jin, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 33
Qinying Wang, Fanying Guo, Yutao Jin, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 33
Plasma proteomic signature of fatty liver disease: The Rotterdam Study
Yasir J. Abozaid, Ibrahim Ayada, Laurens A. van Kleef, et al.
Hepatology (2023) Vol. 78, Iss. 1, pp. 284-294
Closed Access | Times Cited: 15
Yasir J. Abozaid, Ibrahim Ayada, Laurens A. van Kleef, et al.
Hepatology (2023) Vol. 78, Iss. 1, pp. 284-294
Closed Access | Times Cited: 15
Drug Metabolism of Hepatocyte-like Organoids and Their Applicability in In Vitro Toxicity Testing
Manon Bouwmeester, Yu Tao, Susana Proença, et al.
Molecules (2023) Vol. 28, Iss. 2, pp. 621-621
Open Access | Times Cited: 14
Manon Bouwmeester, Yu Tao, Susana Proença, et al.
Molecules (2023) Vol. 28, Iss. 2, pp. 621-621
Open Access | Times Cited: 14
Liver organoids: established tools for disease modeling and drug development
Xicheng Sun, Defu Kong, Jie Zhao, et al.
Hepatology Communications (2023) Vol. 7, Iss. 4
Open Access | Times Cited: 13
Xicheng Sun, Defu Kong, Jie Zhao, et al.
Hepatology Communications (2023) Vol. 7, Iss. 4
Open Access | Times Cited: 13
Mini liver organoid models emulating metabolic dysfunction-associated steatotic disease development: gradually emerging beneath the iceberg
Ting Feng, Junmin Li, Xiaoyi Ma, et al.
Metabolism and Target Organ Damage (2025) Vol. 5, Iss. 1
Open Access
Ting Feng, Junmin Li, Xiaoyi Ma, et al.
Metabolism and Target Organ Damage (2025) Vol. 5, Iss. 1
Open Access
Resmetirom directly inhibits lipid accumulation in human liver-derived organoids
Jiajing Li, Ibrahim Ayada, Qiuwei Pan
Journal of Hepatology (2025)
Closed Access
Jiajing Li, Ibrahim Ayada, Qiuwei Pan
Journal of Hepatology (2025)
Closed Access
From gut to liver: organoids as platforms for next-generation toxicology assessment vehicles for xenobiotics
Sulaiman Mohammed Alnasser
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access
Sulaiman Mohammed Alnasser
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access
Protective Effects of a Standardized Water Extract from the Stem of Ipomoea batatas L. Against High-Fat Diet-Induced Obesity
Chae-Won Lee, Ye Seul Yoon, Young‐Seo Yoon, et al.
Nutrients (2025) Vol. 17, Iss. 10, pp. 1643-1643
Open Access
Chae-Won Lee, Ye Seul Yoon, Young‐Seo Yoon, et al.
Nutrients (2025) Vol. 17, Iss. 10, pp. 1643-1643
Open Access
Human Hepatobiliary Organoids: Recent Advances in Drug Toxicity Verification and Drug Screening
H. Fang, Haoying Xu, Jiong Yu, et al.
Biomolecules (2024) Vol. 14, Iss. 7, pp. 794-794
Open Access | Times Cited: 3
H. Fang, Haoying Xu, Jiong Yu, et al.
Biomolecules (2024) Vol. 14, Iss. 7, pp. 794-794
Open Access | Times Cited: 3
Recapitulating infection, thermal sensitivity and antiviral treatment of seasonal coronaviruses in human airway organoids
Pengfei Li, Yining Wang, Mart M. Lamers, et al.
EBioMedicine (2022) Vol. 81, pp. 104132-104132
Open Access | Times Cited: 14
Pengfei Li, Yining Wang, Mart M. Lamers, et al.
EBioMedicine (2022) Vol. 81, pp. 104132-104132
Open Access | Times Cited: 14
Metabolomic analysis of serum samples from a clinical study on ipragliflozin and metformin treatment in Japanese patients with type 2 diabetes: Exploring human metabolites associated with visceral fat reduction
Ayano Tsukagoshi‐Yamaguchi, Masaya Koshizaka, Ryoichi Ishibashi, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2023) Vol. 43, Iss. 12, pp. 1317-1326
Closed Access | Times Cited: 6
Ayano Tsukagoshi‐Yamaguchi, Masaya Koshizaka, Ryoichi Ishibashi, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2023) Vol. 43, Iss. 12, pp. 1317-1326
Closed Access | Times Cited: 6
Mice hepatic organoids for modeling nonalcoholic fatty liver disease and drug response
Zheng Zhou, Xiyan Zheng, Maoyun Xie, et al.
Stem Cells and Development (2024) Vol. 33, Iss. 15-16, pp. 387-398
Closed Access | Times Cited: 1
Zheng Zhou, Xiyan Zheng, Maoyun Xie, et al.
Stem Cells and Development (2024) Vol. 33, Iss. 15-16, pp. 387-398
Closed Access | Times Cited: 1
Patient-derived organoid models to decode liver pathophysiology
Benjamin J. Dwyer, Janina E. E. Tirnitz‐Parker
Trends in Endocrinology and Metabolism (2024)
Open Access
Benjamin J. Dwyer, Janina E. E. Tirnitz‐Parker
Trends in Endocrinology and Metabolism (2024)
Open Access
Interaction of high lipogenic states with titanium on osteogenesis
Thaís Silva Pinto, Bram C. J. van der Eerden, Marijke Schreuders‐Koedam, et al.
Bone (2024) Vol. 188, pp. 117242-117242
Closed Access
Thaís Silva Pinto, Bram C. J. van der Eerden, Marijke Schreuders‐Koedam, et al.
Bone (2024) Vol. 188, pp. 117242-117242
Closed Access
Evaluating the nutritional value of functional molecules for food processing using tissue and organoid models
Andrew C.A. Wan
Trends in Food Science & Technology (2024) Vol. 156, pp. 104834-104834
Closed Access
Andrew C.A. Wan
Trends in Food Science & Technology (2024) Vol. 156, pp. 104834-104834
Closed Access
